Pinnacle Bancorp’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Pinnacle Bancorp's DGX Position: Q2 2026 in Review
Pinnacle Bancorp increased its Quest Diagnostics (DGX) stake by 224% in Q2 2026, buying an estimated $29.4K and bringing the position to 217 shares worth $46K. The position accounts for 0.01% of the portfolio, ranked #474.
Pinnacle Bancorp first reported a position in DGX in Q1 2017 and has held it in 28 quarters since. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Pinnacle Bancorp held 217 shares of Quest Diagnostics worth $46K as of Q2 2026.
- Pinnacle Bancorp bought 150 Quest Diagnostics shares in Q2 2026, an estimated $29.4K.
- Quest Diagnostics made up 0.01% of Pinnacle Bancorp's portfolio in Q2 2026, its #474 holding.
- Pinnacle Bancorp first reported a position in Quest Diagnostics in Q1 2017 and has held it in 28 quarters since.
- 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Pinnacle Bancorp's 13F filing for Q2 2026, filed 28 Jul 2026.